Educational activities

Long-acting injectable buprenorphine for the treatment of opioid dependence

Module 1 of 2: This learning module explores the nature of opioid dependence and the diagnostic criteria for opioid use disorder, then outlines the use of pharmacotherapies in medication assisted treatment of opioid dependence (MATOD) and the benefits of opioid agonist treatment including long-acting injectable buprenorphine (LAIB) products.

Practical use of long-acting injectable buprenorphine for the treatment of opioid dependence

Module 2 of 2: This two-part activity provides education on the various long-acting buprenorphine (LAIB) formulations available in Australia, followed by a practical exercise where the learner goes through the steps of assessing whether a patient is suitable for LAIB treatment, and discusses with them how treatment may help them achieve their goals.

Dementia in primary care: Recognising and managing behavioural and psychological symptoms and physical comorbidities

Behavioural and psychological symptoms of dementia (BPSD) can lead to quality of life impacts in not only the individual with dementia, but also others around them. This module explores the assessment of BPSD using the ABC (antecedent, behaviour, consequence) model, and discusses the management of BPSD using pharmacological and non-pharmacological methods as well as the management of comorbid conditions associated with dementia.

Haemochromatosis: 2. Is it really haemochromatosis? Diagnosis and misdiagnosis

This module provides an overview of hereditary haemochromatosis and the symptoms of iron overload. Participants will gain an understanding of how to interpret iron study results, and how to determine when genetic testing is warranted. The module also covers how to access the therapeutic venesection service offered by the Australian Red Cross Blood Service.

Haemochromatosis: 3. Therapeutic venesection for haemochromatosis

In this module, participants will learn about appropriate induction and maintenance venesection schedules for patients with hereditary haemochromatosis, as well as circumstances that warrant referral to a specialist. Participants will also learn how to access the Australian Red Cross Blood Service (ARCBS) High Ferritin app, and how to use it to screen patients for their eligibility to access therapeutic venesection. The module also looks at how to access local alternatives to the ARCBS therapeutic venesection service.

Haemochromatosis: Preventing harm caused by iron overload with timely diagnosis and best practice management

Haemochromatosis is the most common genetic disorder in Caucasian people of northern European descent, with signs and symptoms that are highly variable. Living with haemochromatosis is an individual journey that requires consistent, medically supported self-management strategies guided by a positive attitude and awareness of their condition to achieve optimal disease management. This activity aims to educate GPs about the genetic cause of hereditary haemochromatosis and management techniques such as therapeutic venesection.

Pages